COVID-19 test provider BGI Genomics raises $300m from Chinese govt agencies

COVID-19 test provider BGI Genomics raises $300m from Chinese govt agencies

Photo: National Cancer Institute / Unsplash

22 February, 2021

BGI BGI Group SDIC

Printed by Unregistered user on Mon, 29 Dec 2025 21:21:45 GMT

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Subscribe to Newsletter

You may also like

BGI Group's gene-sequencing equipment unit moves towards A-share IPO

Chinese genetics major BGI mulls $1b Shanghai IPO for equipment unit

Read more from Greater China

Demand for China’s lithium batteries may fall in 2026 as EV sales slow

Chinese firm LandSpace’s reusable rockets put Musk’s SpaceX on alert